22
Views
1
CrossRef citations to date
0
Altmetric
The John Pratt-Johnson Annual Lecture

Stability of Visual Acuity after the Cessation of Amblyopia Treatment: Review of the Literature

, M.Sc., O.C.(C.), C.O.M.T., , M.Sc., O.C.(C.), C.O.M.T. & , M.D.
Pages 89-98 | Published online: 22 Dec 2017

References

  • PThe Pediatric Eye Disease Investigator Group: Risk of amblyopia recurrence after cessation of treatment. J AAPOS 2004; 8: 420–428.
  • Leiba H, Shimshoni M, Oliver M, Gottesman Y, Levartovsky S: Long-term follow-up of occlusion therapy in amblyopia. Ophthalmology 2001; 108: 1552–1555.
  • Kushner BJ: Functional amblyopia: A purely practical pediatric patching protocol. In: Ophthalmology Annual. New York: Raven Press; 1998. pp. 173–98.
  • Rutstein RP, Fuhr PS: Efficacy and stability of amblyopia therapy. J Optom Vis Sci 1992; 69: 747–754.
  • Sparrow JC, Flynn JT: Amblyopia: A long-term follow-up. J Pediatr Ophthalmol Stabismus 1979; 14: 333–336.
  • Scott WE, Dickey C: Stability of visual acuity in amblyopia patients after visual maturity. Graefes Arch Clin Exp Ophthalmol 1988; 226: 154–157.
  • Levartovsky S, Gottesman N, Shimshoni M, Oliver M: Factors affecting long-term results of successfully treated amblyopia. J Pediatr Ophthalmol Strabismus 1992; 29: 219–223.
  • Levartovsky S, Oliver M, Gottesman N, Shimshoni M: Factors affecting long-term results of successfully treated amblyopia: Initial visual acuity and type of amblyopia. Br J Ophthalmol 1995; 79: 225–228.
  • Gregersen E, Rindziunski OT: Conventional occlusion in the treatment of squint and amblyopia: A 10-year follow-up. Acta Ophthalmol 1965; 434: 62–74.
  • Ching FC, Parks MM, Friendly DS: Practical management of amblyopia. J Pediatr Ophthalmol Strabismus 1986; 23: 12–16.
  • Oster JG, Simon JW, Jenkins P: When is it safe to stop patching? Br J Ophthalmol 1990; 74: 709–711.
  • Malik SR, Virdi PS, Goel BK: Follow-up results of occlusion and pleoptic treatment. Arch Ophthalmol 1975; 53: 620–626.
  • Oliver M, Neumann R, Chaimovitch Y, Gottesman Y, Shimshoni M: Compliance and results of treatment for amblyopia in children above age 8. Am J Ophthalmol 1986; 102: 340–345.
  • Ohlsson J, Baumann M, Sjostrand J, Abrahamsson M: Long-term visual outcome in amblyopia treatment. Br J Ophthalmol 2002; 86: 1148–1151.
  • Hubel DH, Wiesel TN: Binocular interaction in striate cortex of kittens reared with artificial squint. J Neurophysiol 1965; 28: 1041–1059.
  • Daw N: Critical period and amblyopia. Arch Ophthalmol 1998; 116: 502–505.
  • Scott WE, Stratton VB, Fabre J: Full-time occlusion therapy for amblyopia. Am Orthopt J 1980; 30: 125–130.
  • Flynn JT, Cassady JC: Current trends in amblyopia therapy. Ophthalmology 1978; 85: 428–450.
  • Flynn JT, Schiffman J, Feuer W, Corona A: The therapy of amblyopia: An analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Tr Am Ophth Soc 1998; 96: 431–450, discussions 450–453.
  • Beck RW, Moke PS, Turpin AH, Ferris FL, Johnson CA, Birch EE, Cox TA, Blair C, Kraker RT: A computerized method of visual acuity testing: Adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol 2003; 135: 194–205.
  • Scott WE, et al: Amblyopia treatment outcomes. J AAPOS 2005; 9: 107–111.
  • von Noorden GK, Crawford ML: The sensitive period. Trans Ophthalmol Soc UK 1979; 99: 442–446.
  • Keech RV, Kutschke PJ: Upper age limit for the development of amblyopia. J Pediatr Ophthalmol Strabismus 1995; 32: 89–93.
  • Rahi J, Logan S, Timms C, Eggitt IR, Taylor DSI: Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: A population-based study. Lancet 2000; 360: 597–602.
  • The Pediatric Eye Disease Investigator Group: Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 2005; 123: 437–447.
  • Mintz-Hittner HA, Fernandez KM: Successful amblyopia therapy initiated after age 7 years. Arch Ophthalmol 2000; 118: 1535–1541.
  • Park KH, et al: Efficacy of amblyopia therapy initiated after 9 years of age. Eye 2004; 18: 571–574.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.